[1]
“ASSESSMENT OF PTEN TUMOR SUPPRESSOR PROTEIN BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIAS VERSUS CARCINOMAS OVER A FOUR-YEAR PERIOD”, A-JMRHS, vol. 4, no. 2, pp. 1212–1216, Jun. 2026, doi: 10.65605/a-jmrhs.2026.v04.i02.pp1212-1216.